Follow
Hannah J. Vaughan
Hannah J. Vaughan
PhD Student, Johns Hopkins
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Biodegradable polymeric nanoparticles for therapeutic cancer treatments
J Karlsson, HJ Vaughan, JJ Green
Annual review of chemical and biomolecular engineering 9, 105-127, 2018
1962018
Cancer‐targeting nanoparticles for combinatorial nucleic acid delivery
HJ Vaughan, JJ Green, SY Tzeng
Advanced Materials 32 (13), 1901081, 2020
1592020
Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell regulating miRNAs inhibit glioblastoma growth and prolong survival
H Lopez-Bertoni, KL Kozielski, Y Rui, B Lal, H Vaughan, DR Wilson, ...
Nano letters 18 (7), 4086-4094, 2018
1252018
Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo
KL Kozielski, A Ruiz-Valls, SY Tzeng, H Guerrero-Cázares, Y Rui, Y Li, ...
Biomaterials 209, 79-87, 2019
772019
Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma
CG Zamboni, KL Kozielski, HJ Vaughan, MM Nakata, J Kim, LJ Higgins, ...
Journal of Controlled Release 263, 18-28, 2017
562017
Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
HJ Vaughan, CG Zamboni, LF Hassan, NP Radant, D Jacob, RC Mease, ...
Science Advances 8 (29), eabo6406, 2022
192022
High-throughput evaluation of polymeric nanoparticles for tissue-targeted gene expression using barcoded plasmid DNA
J Kim, HJ Vaughan, CG Zamboni, JC Sunshine, JJ Green
Journal of Controlled Release 337, 105-116, 2021
192021
Poly (beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer
HJ Vaughan, CG Zamboni, NP Radant, P Bhardwaj, ER Lechtich, ...
Molecular Therapy-Oncolytics 21, 377-388, 2021
162021
Recent advances in gene therapy for cancer theranostics
HJ Vaughan, JJ Green
Current opinion in biomedical engineering 20, 100300, 2021
62021
Non-viral gene delivery to hepatocellular carcinoma via intra-arterial injection
HJ Vaughan, CG Zamboni, KM Luly, L Li, KL Gabrielson, LF Hassan, ...
International journal of nanomedicine, 2525-2537, 2023
22023
Engineered therapeutic plasmids and nanoparticle delivery vehicles for targeted treatment of hepatocellular carcinoma
H Vaughan
Johns Hopkins University, 2021
22021
A Novel Peptide Prevents Enterotoxin-and Inflammation-Induced Intestinal Fluid Secretion by Stimulating Sodium-Hydrogen Exchanger 3 Activity
NC Zachos, H Vaughan, R Lin, R Sarker, S Est-Witte, M Chakraborty, ...
Gastroenterology 165 (4), 986-998. e11, 2023
12023
Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy
JJ Green, MG Pomper, CG Zamboni, H Vaughan, I Minn
US Patent 11,697,804, 2023
2023
Zachos NC, et al. A Novel Peptide Prevents Enterotoxin-and Inflammation-Induced Intestinal Fluid Secretion by Stimulating Sodium-Hydrogen Exchanger 3 Activity. Gastroenterology …
NC Zachos, H Vaughan, R Lin, R Sarker, S Est-Witte, M Chakraborty, ...
Gastroenterology, 1, 2023
2023
Nanoparticles for Targeted Theranostic Gene Delivery to Hepatocellular Carcinoma
HJ Vaughan, CG Zamboni, N Radant, P Bhardwaj, RC Mease, ...
MOLECULAR THERAPY 28 (4), 10-10, 2020
2020
CADD-04. NANOPARTICLE DELIVERY OF miRNAs TO INHIBIT GBM STEM CELLS
H Lopez, KL Kozielski, Y Rui, B Lal, H Vaughan, DR Wilson, N Mihelson, ...
Neuro-Oncology 20 (suppl_6), vi277-vi277, 2018
2018
Poly (Beta-Amino Ester)-Mediated Cancer-Specificity and Transarterial Delivery to Improve Gene Therapy Targeting to Hepatocellular Carcinoma Lesions
CG Zamboni, HJ Vaughan, KL Kozielski, P Bhardwaj, LJ Higgins, ...
MOLECULAR THERAPY 25 (5), 66-67, 2017
2017
Poly (beta-amino ester) nanoparticles for selective and combinatorial delivery of siRNA to brain cancer
KL Kozielski, H Vaughan, BH Kim, SY Tzeng, H Guerrero-Cazares, ...
MicroRNA delivery via poly (beta-amino ester) nanoparticles as a treatment for human glioblastoma
K Kozielski, H Lopez-Bertoni, B Lal, H Vaughan, J Laterra, JJ Green
The system can't perform the operation now. Try again later.
Articles 1–19